134 related articles for article (PubMed ID: 26320881)
1. Overexpression of CXCR4 on circulating B cells in patients with active systemic lupus erythematosus.
Hanaoka H; Okazaki Y; Hashiguchi A; Yasuoka H; Takeuchi T; Kuwana M
Clin Exp Rheumatol; 2015; 33(6):863-70. PubMed ID: 26320881
[TBL] [Abstract][Full Text] [Related]
2. Dysregulated expression of CXCR4/CXCL12 in subsets of patients with systemic lupus erythematosus.
Wang A; Guilpain P; Chong BF; Chouzenoux S; Guillevin L; Du Y; Zhou XJ; Lin F; Fairhurst AM; Boudreaux C; Roux C; Wakeland EK; Davis LS; Batteux F; Mohan C
Arthritis Rheum; 2010 Nov; 62(11):3436-46. PubMed ID: 20722038
[TBL] [Abstract][Full Text] [Related]
3. CXCR4/CXCL12 hyperexpression plays a pivotal role in the pathogenesis of lupus.
Wang A; Fairhurst AM; Tus K; Subramanian S; Liu Y; Lin F; Igarashi P; Zhou XJ; Batteux F; Wong D; Wakeland EK; Mohan C
J Immunol; 2009 Apr; 182(7):4448-58. PubMed ID: 19299746
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus.
Henneken M; Dörner T; Burmester GR; Berek C
Arthritis Res Ther; 2005; 7(5):R1001-13. PubMed ID: 16207316
[TBL] [Abstract][Full Text] [Related]
5. Contribution and underlying mechanisms of CXCR4 overexpression in patients with systemic lupus erythematosus.
Zhao LD; Liang D; Wu XN; Li Y; Niu JW; Zhou C; Wang L; Chen H; Zheng WJ; Fei YY; Tang FL; Li YZ; Zhang FC; He W; Cao XT; Zhang X
Cell Mol Immunol; 2017 Oct; 14(10):842-849. PubMed ID: 27665947
[TBL] [Abstract][Full Text] [Related]
6. Expression of CXCL12 receptors in B cells from Mexican Mestizos patients with systemic Lupus erythematosus.
Biajoux V; Bignon A; Freitas C; Martinez V; Thelen M; Lima G; Jakez-Ocampo J; Emilie D; Llorente L; Balabanian K
J Transl Med; 2012 Dec; 10():251. PubMed ID: 23244336
[TBL] [Abstract][Full Text] [Related]
7. Infection of Female BWF1 Lupus Mice with Malaria Parasite Attenuates B Cell Autoreactivity by Modulating the CXCL12/CXCR4 Axis and Its Downstream Signals PI3K/AKT, NFκB and ERK.
Badr G; Sayed A; Abdel-Maksoud MA; Mohamed AO; El-Amir A; Abdel-Ghaffar FA; Al-Quraishy S; Mahmoud MH
PLoS One; 2015; 10(4):e0125340. PubMed ID: 25909640
[TBL] [Abstract][Full Text] [Related]
8. TLR4
Ma K; Li J; Wang X; Lin X; Du W; Yang X; Mou F; Fang Y; Zhao Y; Hong X; Chan KW; Zhang X; Liu D; Sun L; Lu L
Ann Rheum Dis; 2018 Oct; 77(10):1498-1506. PubMed ID: 29925508
[TBL] [Abstract][Full Text] [Related]
9. Serum BLC/CXCL13 concentrations and renal expression of CXCL13/CXCR5 in patients with systemic lupus erythematosus and lupus nephritis.
Lee HT; Shiao YM; Wu TH; Chen WS; Hsu YH; Tsai SF; Tsai CY
J Rheumatol; 2010 Jan; 37(1):45-52. PubMed ID: 19955043
[TBL] [Abstract][Full Text] [Related]
10. Targeting the CXCR4/CXCL12 axis in systemic lupus erythematosus.
Chong BF; Mohan C
Expert Opin Ther Targets; 2009 Oct; 13(10):1147-53. PubMed ID: 19670960
[TBL] [Abstract][Full Text] [Related]
11. Plasmablasts With a Mucosal Phenotype Contribute to Plasmacytosis in Systemic Lupus Erythematosus.
Mei HE; Hahne S; Redlin A; Hoyer BF; Wu K; Baganz L; Lisney AR; Alexander T; Rudolph B; Dörner T
Arthritis Rheumatol; 2017 Oct; 69(10):2018-2028. PubMed ID: 28622453
[TBL] [Abstract][Full Text] [Related]
12. Elevated production of serum B-cell-attracting chemokine-1 (BCA-1/CXCL13) is correlated with childhood-onset lupus disease activity, severity, and renal involvement.
Ezzat M; El-Gammasy T; Shaheen K; Shokr E
Lupus; 2011 Jul; 20(8):845-54. PubMed ID: 21576203
[TBL] [Abstract][Full Text] [Related]
13. Control of humoral immunity and auto-immunity by the CXCR4/CXCL12 axis in lupus patients following influenza vaccine.
Launay O; Paul S; Servettaz A; Roguet G; Rozenberg F; Lucht F; Lambert C; Presles E; Goulvestre C; Méritet JF; Galtier F; Dubray C; Lebon P; Weill B; Batteux F
Vaccine; 2013 Aug; 31(35):3492-501. PubMed ID: 23764537
[TBL] [Abstract][Full Text] [Related]
14. Abnormal expression of chemokine receptors on T-cells from patients with systemic lupus erythematosus.
Eriksson C; Eneslätt K; Ivanoff J; Rantapää-Dahlqvist S; Sundqvist KG
Lupus; 2003; 12(10):766-74. PubMed ID: 14596426
[TBL] [Abstract][Full Text] [Related]
15. Urinary T cells in active lupus nephritis show an effector memory phenotype.
Dolff S; Abdulahad WH; van Dijk MC; Limburg PC; Kallenberg CG; Bijl M
Ann Rheum Dis; 2010 Nov; 69(11):2034-41. PubMed ID: 20472588
[TBL] [Abstract][Full Text] [Related]
16. Peripheral circulating activated b-cell populations are associated with nephritis and disease activity in patients with systemic lupus erythematosus.
Dolff S; Wilde B; Patschan S; Dürig J; Specker C; Philipp T; Kribben A; Witzke O
Scand J Immunol; 2007 Nov; 66(5):584-90. PubMed ID: 17868260
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of chemokine receptor expression and function by B cells of patients with primary Sjögren's syndrome.
Hansen A; Reiter K; Ziprian T; Jacobi A; Hoffmann A; Gosemann M; Scholze J; Lipsky PE; Dörner T
Arthritis Rheum; 2005 Jul; 52(7):2109-19. PubMed ID: 15986367
[TBL] [Abstract][Full Text] [Related]
18. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to the generation of plasma B cells.
Nakou M; Papadimitraki ED; Fanouriakis A; Bertsias GK; Choulaki C; Goulidaki N; Sidiropoulos P; Boumpas DT
Clin Exp Rheumatol; 2013; 31(2):172-9. PubMed ID: 23137515
[TBL] [Abstract][Full Text] [Related]
20. Correlation between the renal C1q deposition and serum anti-C1q antibody: a potential role of anti-C1q antibody in lupus nephritis.
Chen PC; Wang CR; Liu MF; Chen FF; Liang CC
Asian Pac J Allergy Immunol; 2002 Dec; 20(4):223-7. PubMed ID: 12744622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
